RT Journal Article SR Electronic T1 Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.01.27.22269965 DO 10.1101/2022.01.27.22269965 A1 Karthik Gangavarapu A1 Alaa Abdel Latif A1 Julia L. Mullen A1 Manar Alkuzweny A1 Emory Hufbauer A1 Ginger Tsueng A1 Emily Haag A1 Mark Zeller A1 Christine M. Aceves A1 Karina Zaiets A1 Marco Cano A1 Jerry Zhou A1 Zhongchao Qian A1 Rachel Sattler A1 Nathaniel L Matteson A1 Joshua I. Levy A1 Marc A. Suchard A1 Chunlei Wu A1 Andrew I. Su A1 Kristian G. Andersen A1 Laura D. Hughes YR 2022 UL http://medrxiv.org/content/early/2022/01/29/2022.01.27.22269965.abstract AB The emergence of SARS-CoV-2 variants has prompted the need for near real-time genomic surveillance to inform public health interventions. In response to this need, the global scientific community, through unprecedented effort, has sequenced over 7 million genomes as of December 2021. The extraordinarily high sampling rate provides a unique opportunity to track the evolution of the virus in near real-time. Here, we present outbreak.info, a platform that can be used to track over 40 million combinations of PANGO lineages and individual mutations, across over 7,000 locations, to provide insights for researchers, public health officials, and the general public. We describe the data pipelines that enable the scalable ingestion and standardization of heterogeneous data on SARS-CoV-2 variants, the server infrastructure that enables the dissemination of the processed data, and the client-side applications that provide intuitive visualizations of the underlying data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute for Allergy and Infectious Diseases (5 U19 AI135995-02, 5 U19 AI135995-03S2, 5 U19 AI135995-04S3, R01 AI162611, R01 AI153044), National Center For Advancing Translational Sciences (5 U24 TR002306), and Centers for Disease Control and Prevention (75D30120C09795).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://outbreak.info/ https://outbreak.info/